Campylobacter spp. are food-and water borne pathogens. While rather accurate estimates for these 50 pathogens are available in industrialized countries, a lack of diagnostic capacity in developing 51 countries limits accurate assessments of prevalence in many regions. Proficiency in the 52 identification and susceptibility testing of these organisms is critical for surveillance and control 53 efforts. The aim of the study was to assess performance for identification and susceptibility testing 54 of thermo-tolerant Campylobacter among laboratories participating in the World Health 55 Organization (WHO) Global Foodborne Infections Network (GFN) External Quality Assurance 56 System (EQAS) over a nine year period. 57 Participants (primarily national level laboratories) were encouraged to self-evaluate performance as 58 part of continuous quality improvement. 59 The ability to correctly identify Campylobacter spp. varied by year and ranged from 61.9 % (2008) 60 to 90.7 % (2012), and the ability to correctly perform antimicrobial susceptibility testing (AST) for 61 Campylobacter spp. appeared to steadily increase from 91.4 % to 93.6 % in the test period (2009-62 2012). 63 Poorest performance (60.0 % correct identification and 86.8 % correct AST results) was observed in 64 African laboratories. 65
Introduction
(http://www.antimicrobialresistance.dk/233-169-215-eqas.htm) described how to revive and test the 137 isolates and referred to a manual on sub-culturing and maintenance of quality control (QC) strains.
139
For the identification component, the protocol specified that the laboratory's routine methods 140 should be applied. Laboratories were free to utilize conventional phenotypic identification, 141 molecular identification, or a combination of methods for identification. Laboratories who participated only in the AST component (did not perform identification), were provided upon 143 request the identification of the coded Campylobacter strains. 144 While multiple methods were used for identification; during this period, time validated methods for 145 susceptibility testing of Campylobacter by disk diffusion or E-test were not internationally 146 available. As such only broth or agar dilution methods (MIC) were accepted for the AST To assess potential differences between regions in the AST performance, the proportion of correct 177 AST result for each antibiotic (CHL, CIP, ERY, GEN, NAL, STR and TET) was analyzed for 178 significant differences between regions using the prop.test function in the stat R-package stats. Caribbean (0, 0, 0, 1); Europe (7, 9, 7, 11) ; Latin America (4, 7, 6, 6); North America (1, 2, 2, 2);
198
Oceania (0, 0, 1, 0); Russian region (0, 1, 1, 0); Southeast Asia (4, 5, 4, 6) . The cumulative number There was a strong significant difference between the regions as to the proportion of correctly 212 identified Campylobacter species, with Oceania and North America exhibiting the highest, and 213 Africa and the Caribbean the lowest proportions of correctly identified Campylobacter species 214 ( Figure 3 ). It is important to consider that in some regions (e.g. Oceania), participation was limited 215 (n=1) and may fail to truly reflect regional capacity. Deviations appeared to be in particular caused by streptomycin with a deviation level at 11.5 %, but 233 also for erythromycin, tetracycline and ciprofloxacin, fairly high deviation levels were seen (8.5 %, In the four iterations, 51 (75 %) laboratories uploaded one or more values for the QC reference 248 strain, C. jejuni ATCC 33560 suggesting that 25 % of the labs did not test QC strain for reference.
249
Of the submitted values for the QC reference strain, an average of 17.2 % were out of the QC range 250 when evaluated towards one of the validated methods described by CLSI (e.g. VET01-A4) (8).
251 Analysis of regional differences in this context reveals Africa as the region with the highest level of 252 laboratories submitting AST results for the Campylobacter test strains without submitting results 253 for the C. jejuni ATCC 33560 reference strain. The proficiency test results are intended to be utilized for continuous quality improvement.
257
However, some participating laboratories did not demonstrate improvement in identification or AST The frequent incidence of Campylobacter diarrhea, increasing drug resistance, and the potential for 282 long term sequelae, highlight the importance of accurately understanding the socio-economic burden of campylobacteriosis (4). Increased competence of reference laboratories for identification 284 and AST C. jejuni and C. coli therefore support disease surveillance and control programs. The self-evaluation design of this proficiency test was intended to challenge the participating 296 laboratories to assess their current identification and AST methods for Campylobacter also allowing 297 them to include the proficiency test outcome as an external quality assessment of the relevant 298 methods. Self-evaluation is a concept well-known to laboratories following a quality assurance 299 standard requiring quality control procedures e.g. ISO/IEC 17025 (9) and might include monitoring In addition to self-evaluation, the possibility of introducing approaches like mentoring of 308 participants, training courses, and E-learning could be explored and suggested to the participants.
309
The question of resources must, however, be considered, for example, mentoring of participants 310 appears to be a rewarding but also is a resource demanding approach of capacity building Regional 311 follow-up is likely to be a rewarding approach and should be based on evaluation of regional needs 312 and challenges. Especially for the African region and Southeast Asia, it appears that specific follow-313 up is required. For example, the submitted results for the AST component indicate that many 314 laboratories did not perform adequate internal quality control (17.2 % of submitted results for the 315 ATCC reference strain were out of range), which is why WHO GFN capacity building efforts focus 316 at encouraging the maintenance of relevant quality assurance as part of the laboratory routines.
317
Internal laboratory QA ensures minimization of variable factors influencing the obtained result for a 318 test strain. These factors include the media content, the activity of the antimicrobial, and the testing 319 of a QC reference strain according to an internationally recognized standard (e.g. CLSI). 
